Moderate Ulcerative colitis
Also known as: Ulcerative Colitis, Active Moderate / Moderate, active Ulcerative colitis
Drug | Drug Name | Drug Description |
---|---|---|
DB01014 | Balsalazide | An aminosalicylate used to treat ulcerative colitis. |
DB06674 | Golimumab | A TNFα inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. |
DB00244 | Mesalazine | An aminosalicylate drug used to treat mild to moderate active ulcerative colitis and also to maintain remission once achieved. |
DB05679 | Ustekinumab | A targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB17743 | Fecal microbiota | 0 | Unknown Status | 1 |
DB16660 | Izencitinib | 1 | Completed | 1 |
DB05429 | Bertilimumab | 2 | Unknown Status | 1 |